ArticleCancers2020
The Spectrum of
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 12 citations in OpenAlex.
- Gender-Specific Genetic Predisposition to Breast Cancer:Cancers · 2024Review
- Spectrum and Frequency of GermlineCancers · 2023Article
- Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population.International journal of molecular sciences · 2023Article
- Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors.Frontiers in immunology · 2022Article
- Article
- FANCM regulates repair pathway choice at stalled replication forks.Molecular cell · 2021Article
- Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.Genes, chromosomes & cancer · 2021Article
- Article
- Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients.Cancers · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
72 authors at 20 institutions in 15 countries.
Gisella FiglioliGenome Diagnostics Program, IFOM - the FIRC Institute for Molecular Oncology, Milan 20139, Italy.
Anders KvistDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden.
Emma ThamDepartment of Clinical Genetics, Karolinska University Hospital and Department of Molecular Medicine, Karolinska Institutet, Stockholm 17176, Sweden.
Jana SoukupovaInstitute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic.
Petra KleiblovaInstitute of Biology and Medical Genetics, General University Hospital and First Faculty of Medicine, Charles University, Prague 12800, Czech Republic.
Taru A MuranenDepartment of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland.
Nadine AndrieuInserm, U900, Institut Curie, PSL University, Paris F-75005, France.
Jacopo AzzolliniDepartment of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Judith BalmañaHereditary Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.
Alicia BarrosoHuman Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.
Javier BenítezHuman Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.
Birgitte BertelsenCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
Ana BlancoFundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.
Bernardo BonanniDivision of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy.
Åke BorgDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden.
Joan BrunetHereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain.
Daniele CalistriBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy.
Mariarosaria CalvelloDivision of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy.
Stepan ChvojkaCentre for Medical Genetics and Reproductive Medicine, Gennet, Prague 17000, Czech Republic.
Laura CortesiUniversity Modena Hospital, Modena 41124, Italy.
Esther DarderHereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain.
Jesús Del ValleHereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain.
Orland DiezHereditary Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.
ENIGMA ConsortiumQIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
Séverine Eon-MarchaisInserm, U900, Institut Curie, PSL University, Paris F-75005, France.
Florentia FostiraInRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research "Demokritos", Athens 15310, Greece.
GENESIS Study CollaboratorsInserm, U900, Institut Curie, PSL University, Paris F-75005, France.
Francesca GensiniDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50134, Italy.
Claude HoudayerGenetics Department, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, Rouen, France.
Marketa JanatovaInstitute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic.
Johanna I KiiskiDepartment of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland.
Irene KonstantopoulouInRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research "Demokritos", Athens 15310, Greece.
Katerina Kubelka-SabitDepartment of Histopathology and Cytology, Clinical Hospital Acibadem Sistina, Skopje 1000, Republic of North Macedonia.
Conxi LázaroHereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain.
Fabienne LesueurInserm, U900, Institut Curie, PSL University, Paris F-75005, France.
Siranoush ManoukianDepartment of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Ruta MarcinkuteHereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.
Ugnius MickysNational Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.
Virginie MoncoutierService de Génétique, Institut Curie, Inserm, U830, Paris Descartes University, Paris F-75005, France.
SWE-BRCA GroupDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund SE-22100, Sweden.
Aleksander MyszkaInstitute of Medical Sciences, University of Rzeszow, Rzeszow 35-310, Poland.
Tu Nguyen-DumontPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton 3168, Australia.
Finn Cilius NielsenCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
Rimvydas NorvilasHereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.
Edith OlahDepartment of Molecular Genetics, National Institute of Oncology, Budapest 1122, Hungary.
Ana OsorioHuman Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.
Laura PapiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50134, Italy.
Bernard PeisselDepartment of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Ana PeixotoDepartment of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal.
Dijana Plaseska-KaranfilskaResearch Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje 1000, Republic of North Macedonia.ORCID 0000-0002-5190-0389
Timea PóczaDepartment of Molecular Genetics, National Institute of Oncology, Budapest 1122, Hungary.
Maria RossingCenter for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
Vilius RudaitisDepartment of Gynaecology, Center of Obsterics and Gynaecology, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.
Marta SantamariñaFundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.
Catarina SantosDepartment of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal.
Snezhana SmichkoskaMedical Faculty, University Clinic of Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, Skopje 1000, Republic of North Macedonia.
Melissa C SoutheyPrecision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton 3168, Australia.
Dominique Stoppa-LyonnetService de Génétique, Institut Curie, Inserm, U830, Paris Descartes University, Paris F-75005, France.
Manuel TeixeiraDepartment of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal.
Therese TörngrenDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden.
Angela TossUniversity Modena Hospital, Modena 41124, Italy.
Miguel UriosteFamilial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.
Ana VegaFundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.
Zdenka VlckovaDepartment of Medical Genetics, GHC Genetics, Prague 11000, Czech Republic.
Drakoulis YannoukakosInRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research "Demokritos", Athens 15310, Greece.
Valentina ZampigaBiosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy.
Zdenek KleiblInstitute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic.
Paolo RadiceDepartment of Research, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Heli NevanlinnaDepartment of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland.
Hans EhrencronaDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund SE-22100, Sweden.
Ramunas JanaviciusHereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.
Paolo PeterlongoGenome Diagnostics Program, IFOM - the FIRC Institute for Molecular Oncology, Milan 20139, Italy.
Inserm · FRVilnius University · LTCharles University · CZSpanish National Cancer Research Centre · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversity of Helsinki · FIFondazione IRCCS Istituto Nazionale dei Tumori · ITInstituto Português de Oncologia Francisco Gentil · PTLund University · SENational Centre of Scientific Research "Demokritos" · GRThe University of Melbourne · AUUniversity of Modena and Reggio Emilia · ITCentre for Biomedical Network Research on Rare Diseases · ESCopenhagen University Hospital · DKEuropean Institute of Oncology · ITIFOM · ITMacedonian Academy of Sciences and Arts · MKVall d'Hebron Hospital Universitari · ESAcıbadem Adana Hospital · TRGennet · CZ
Funding
Associazione Italiana per la Ricerca sul Cancro 16732
Abstract
Germline protein truncating variants (PTVs) in the
Indexed as
breast cancer predispositionbreast cancer risk factorsFANCM truncating variantsmutation spectrumPTVs
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.